Can-Fite BioPharma Ltd.

AMEX: CANF · Real-Time Price · USD
0.66
-0.01 (-1.79%)
At close: Aug 15, 2025, 3:59 PM
0.65
-1.62%
After-hours: Aug 15, 2025, 07:19 PM EDT

Can-Fite BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.83M 4.28M 2.98M 4.39M
Short-Term Investments
3.06M 4.64M 5M 14.75M
Long-Term Investments
n/a n/a 8K n/a
Other Long-Term Assets
n/a n/a -8K -185K
Receivables
n/a n/a 47K 48K
Inventory
n/a n/a -39K -48K
Other Current Assets
1.09M 78K n/a n/a
Total Current Assets
8.98M 9.91M 9.16M 20.07M
Property-Plant & Equipment
138K 81K 126K 185K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
138K 81K 126K 185K
Total Assets
9.12M 9.99M 9.28M 20.25M
Account Payables
618K 427K 896K 954K
Deferred Revenue
405K 622K 783K 818K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
675K 694K 492K 603K
Total Current Liabilities
2.05M 2.02M 2.5M 2.73M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
1.63M 1.73M 2.31M 3.14M
Total Liabilities
3.68M 3.75M 4.81M 5.87M
Total Debt
104K 40K 62K 124K
Common Stock
n/a n/a n/a 60.65M
Retained Earnings
-166.36M -158.48M -150.85M -140.67M
Comprehensive Income
1.13M 1.13M 1.13M 1.13M
Shareholders Equity
5.44M 6.24M 4.47M 14.38M
Total Investments
3.06M 4.64M 5.01M 14.75M